tiprankstipranks
Cyclacel Pharmaceuticals (CYCC)
NASDAQ:CYCC

Cyclacel Pharmaceuticals (CYCC) Stock Investors

626 Followers
Based on 743,457 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold CYCC
On average, investors allocate 0.00% of their portfolios to CYCC
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Positive
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 743,457 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding CYCC

1.2%
Last 7
Days
17.3%
Last 30
Days
Percentages indicate the change in the number of portfolios holding CYCC, out of 743,457 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

CYCC Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Increased
0.71%
$1.94
Based on the activity of 14,071 investors who made their portfolios public
The table shows changes in CYCC in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

CYCC Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
DraftKings
5.75%
-0.33%
-1.13%
33.50B
Consumer Cyclical
Coherus Biosciences
2.58%
-1.16%
-5.09%
198.48M
Healthcare
Delta Air Lines
5.37%
+0.14%
-0.08%
30.61B
Industrials
Bristol-Myers Squibb
3.22%
+0.24%
+1.64%
84.19B
Healthcare
Raytheon Technologies
4.01%
-1.07%
-2.52%
133.47B
Industrials
Plug Power
4.96%
-0.79%
-3.15%
1.73B
Industrials
ChargePoint Holdings
4.01%
-0.45%
-2.39%
642.21M
Consumer Cyclical
Marathon Digital Holdings
5.55%
-0.09%
-1.20%
5.42B
Financial
Enterprise Products Partners
5.77%
-0.43%
+0.66%
62.93B
Energy
GE Aerospace
5.28%
-0.21%
+0.49%
174.01B
Industrials
Based on the activity of 743,457 active portfolios
Open your Smart Portfolio

CYCC Investor Analysis

CYCC investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
4.5%
of CYCC holders
are under 35
Average Segment Performance
Average P/E Ratio21.46
Beta7.39
Dividend Yield6.06%
CYCC investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
34.8%
of CYCC holders
are between 35–55
Average Segment Performance
Average P/E Ratio20.66
Beta13.51
Dividend Yield6.08%
CYCC investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
60.7%
of CYCC holders
are over 55
Average Segment Performance
Average P/E Ratio20.71
Beta4.77
Dividend Yield7.20%
Overview of age group and performance of CYCC stock investors
See who invests in CYCC according to age group and performance.

FAQ

How many retail Investors hold CYCC?
<0.1% of TipRanks' retail investors hold CYCC in their portfolios.
    What is CYCC Investor Sentiment?
    CYCC’s Investor Sentiment is Very Positive.
      What percentage of retail investors changed their holding of CYCC in the last 7 days?
      ▼ 1.2% of TipRanks' retail investors changed their holding of CYCC in the last 7 days.
        What percentage of retail investors changed their holding of CYCC in the last 30 days?
        ▲ 17.3% of TipRanks' retail investors changed their holding of CYCC in the last 30 days.
          What is the average age of retail investors who hold CYCC?
          The average age of CYCC Holders is over 55.
            What other stocks have CYCC investors also bought?
            CYCC Investors also bought DKNG, CHRS, DAL, BMY, RTX, PLUG, CHPT, MARA, EPD, GE.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              AZNAstraZeneca
              BCRXBioCryst
              BSXBoston Scientific
              DVADaVita
              EWEdwards Lifesciences
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis